FcγRIIB in IgG-mediated suppression of antibody responses:: Different impact in vivo and in vitro

被引:52
作者
Karlsson, MCI [1 ]
Getahun, A [1 ]
Heyman, B [1 ]
机构
[1] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, SE-75185 Uppsala, Sweden
关键词
D O I
10.4049/jimmunol.167.10.5558
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
pression is used clinically in rhesus prophylaxis to prevent RhD-negative mothers from becoming immunized against their Ph D-positive fetuses. We have recently,shown that IgG anti-SRBC, passively administered together with SRBC, can induce efficient suppression of primary Ab responses to SRBC in mice lacking the known FcRs for IgG (Fc gamma RI, Fc gamma III, and Fc gamma RIIB or the neonatal FcR). The lack of a demonstrable effect of the inhibitory Fc gamma RIIB was particularly surprising, and, in this study, the involvement of this receptor is further investigated during broader experimental conditions. The data show that SRBC-specific IgG administered up to 5 days after SRBC can induce suppression both in wild-type and Fc gamma RIIB-deficient mice. Suppression of secondary Ab responses to SRBC in vivo was similar in the two strains. In contrast, IgG-mediated suppression of Ab responses in Nitro was impaired in cultures with primed Fc gamma RIIB-deficient spleen cells. In conclusion, inhibition of in vivo Ab responses to SRBC by passively administered IgG can take place via an Fc gamma RIIB-independent pathway. This pathway causes > 99% suppression and operates during all experimental conditions studied so far. The nature of the mechanism can at present only be hypothesized. Masking of epitopes and/or rapid elimination of IgG-Ag complexes would both be compatible with the observations.
引用
收藏
页码:5558 / 5564
页数:7
相关论文
共 37 条
[1]   FC-GAMMA-RII EXPRESSION IN RESTING AND ACTIVATED LYMPHOCYTES-B [J].
AMIGORENA, S ;
BONNEROT, C ;
CHOQUET, D ;
FRIDMAN, WH ;
TEILLAUD, JL .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (08) :1379-1385
[2]   CYTOPLASMIC DOMAIN HETEROGENEITY AND FUNCTIONS OF IGG FC-RECEPTORS IN LYMPHOCYTES-B [J].
AMIGORENA, S ;
BONNEROT, C ;
DRAKE, JR ;
CHOQUET, D ;
HUNZIKER, W ;
GUILLET, JG ;
WEBSTER, P ;
SAUTES, C ;
MELLMAN, I ;
FRIDMAN, WH .
SCIENCE, 1992, 256 (5065) :1808-1812
[3]   CROSSLINKING OF SURFACE-IMMUNOGLOBULIN AND FC-RECEPTORS ON LYMPHOCYTES-B INHIBITS STIMULATION OF INOSITOL PHOSPHOLIPID BREAKDOWN VIA THE ANTIGEN RECEPTORS [J].
BIJSTERBOSCH, MK ;
KLAUS, GGB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (06) :1825-1836
[4]  
Bowman J M, 1988, Transfus Med Rev, V2, P129, DOI 10.1016/S0887-7963(88)70039-5
[5]   STUDIES ON CONTROL OF ANTIBODY SYNTHESIS - INTERACTION OF ANTIGENIC COMPETITION AND SUPPRESSION OF ANTIBODY FORMATION BY PASSIVE ANTIBODY ON IMMUNE RESPONSE [J].
BRODY, NI ;
WALKER, JG ;
SISKIND, GW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1967, 126 (01) :81-&
[6]   REGULATION OF THE ANTIBODY-RESPONSE AGAINST HAPTEN-COUPLED ERYTHROCYTES BY MONOCLONAL ANTI-HAPTEN ANTIBODIES OF VARIOUS ISOTYPES [J].
BRUGGEMANN, M ;
RAJEWSKY, K .
CELLULAR IMMUNOLOGY, 1982, 71 (02) :365-373
[7]  
CEROTTINI JC, 1969, J IMMUNOL, V102, P1008
[8]  
CHAN PL, 1973, IMMUNOLOGY, V24, P289
[9]  
ENRIQUEZRINCON F, 1984, IMMUNOLOGY, V52, P129
[10]   ISOLATION OF PURE IGG1, IGG2A AND IGG2B IMMUNOGLOBULINS FROM MOUSE SERUM USING PROTEIN A-SEPHAROSE [J].
EY, PL ;
PROWSE, SJ ;
JENKIN, CR .
IMMUNOCHEMISTRY, 1978, 15 (07) :429-436